(19)
(11) EP 0 757 687 A1

(12)

(43) Date of publication:
12.02.1997 Bulletin 1997/07

(21) Application number: 95911322.0

(22) Date of filing: 09.03.1995
(51) International Patent Classification (IPC): 
C07D 491/ 048( . )
A61K 31/ 44( . )
A61P 25/ 04( . )
A61P 25/ 20( . )
A61P 25/ 26( . )
A61P 25/ 30( . )
C07D 401/ 12( . )
C07D 491/ 04( . )
C07D 495/ 04( . )
A61K 31/ 435( . )
A61K 31/ 4427( . )
A61P 25/ 18( . )
A61P 25/ 24( . )
A61P 25/ 28( . )
A61P 43/ 00( . )
C07D 471/ 04( . )
C07D 491/ 044( . )
(86) International application number:
PCT/EP1995/000901
(87) International publication number:
WO 1995/029177 (02.11.1995 Gazette 1995/47)
(84) Designated Contracting States:
BE CH DE FR GB IT LI NL

(30) Priority: 23.04.1994 GB 19940008097
25.05.1994 GB 19940010506

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventors:
  • KING, Francis D., SmithKline Beecham Pharm.
    Harlow Essex CM19 5AD (GB)
  • HAM, Peter., SmithKline Beecham Pharmaceuticals
    Harlow Essex CM19 5AD (GB)
  • FORBES, Ian T., SmithKline Beecham Pharm.
    Essex CM19 5AD (GB)
  • JONES, Graham E., SmithKline Beecham Pharm.
    Essex CM19 5AD (GB)

(74) Representative: Summersell, Richard John, Dr. 
SmithKline Beecham plc, Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) TRICYCLIC DERIVATIVES AS 5HT 2C? AND 5HT 2B? ANTAGONISTS